NEW YORK / RankWire.AI / – Global health authorities leveraged a gathering at the UN General Assembly to advocate for nations to lead the adoption of artificial intelligence in efforts to eliminate diseases. The event gathered ministers, public health experts, funders, and diagnostics specialists. The Global Institute for Disease Elimination, known as GLIDE, co-hosted the session alongside the RBM Partnership to End Malaria and Nigeria. The conversations centered on disease monitoring, health system planning, resource distribution, and the prerequisites for responsible AI deployment.
The speakers emphasized that government authorities should steer the decision-making process regarding the integration and management of AI tools within health systems. Michael Adekunle Charles, CEO of the RBM Partnership to End Malaria, addressed the gathering on behalf of Nigeria’s health minister, Muhammad Ali Pate. Nigeria is actively pursuing its Health Sector Renewal Investment Initiative, which encompasses primary healthcare, health financing, workforce development, and enhancement of data infrastructure. Attendees also stressed the importance of aligning emerging technologies with existing national health priorities.
The discussion explored the practical needs for expanding AI use across various disease control initiatives. Key requirements identified by participants included access to trustworthy data, a well-trained health workforce, sustainable funding sources, and seamless integration with existing systems. Malaria continues to be a central focus for international health organizations. According to estimates from the World Health Organization, there were 282 million malaria cases globally in 2024, resulting in 610,000 fatalities. The WHO African Region bore the greatest share of this burden, with Nigeria reporting the highest estimated number of malaria cases.
New AI Education Initiatives Aim to Strengthen Public Health Leadership
GLIDE announced two new training programs aimed at enhancing artificial intelligence literacy among public health leaders. The GLIDE Leadership Excellence in AI for Health program is scheduled to bring senior decision-makers to Abu Dhabi from January 17 to 22, 2027. The inaugural residential cohort will consist of between 25 and 30 participants. The curriculum will include topics such as AI governance, organizational readiness, deployment strategies, and accountability measures. The program targets officials responsible for health policy and national disease programs.
Mohamed bin Zayed University of Artificial Intelligence collaborated with GLIDE to develop a second initiative, AI for All, designed for public health professionals. This online course comprises four modules and is accessible without prior coding experience. It covers fundamental AI principles, generative AI, issues of bias, privacy concerns, accountability, and human oversight. The program aims to provide health practitioners with a foundational understanding to evaluate AI tools within public health contexts. It also offers guidance on how organizations can assess new technologies before integrating them into their operational workflows.
Partnership Enhances Technical Support for Malaria Eradication
During the New York event, GLIDE and the RBM Partnership to End Malaria formalized their collaboration through a mutual understanding agreement. This document connects technical expertise, innovative approaches, and capacity building efforts with the strategic priorities of national malaria programs. The partnership aims to support country-led malaria control and elimination strategies. Additionally, it aligns with the World Health Organization’s Global Technical Strategy for Malaria, which aims to reduce cases and deaths from malaria through 2030 by strengthening surveillance and health system resilience.
The broader dialogue also included discussions on polio and neglected tropical diseases alongside malaria. Participants examined how AI can enhance disease surveillance, inform programmatic decisions, and optimize resource utilization. The event prioritized national health authorities in the decision-making process concerning technological advancements. Organizers highlighted the importance of capacity building and training as countries explore the adoption of digital tools. The initiatives introduced in New York linked AI education, technical collaboration, and leadership development with ongoing efforts to eradicate preventable infectious diseases.